ON 108600
/ Traws Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 25, 2019
A novel inhibitor of cancer stem cells overcomes chemotherapy resistance of triple negative breast cancers
(SABCS 2019)
- "Conclusions : ON108600, identified as an inhibitor of a cancer stem cell-like population, overcomes Paclitaxel resistance to suppress growth of aggressive TNBC for which treatment options remain limited. These results support further study and clinical translation of ON108600."
Cancer stem cells
1 to 1
Of
1
Go to page
1